State of the Global Biotech Landscape: Where the Opportunities Lie


The last five years has been a unique time period for the global biotech and pharmaceutical landscape, encompassing the COVID-19 pandemic and all the challenges and opportunities it created. Clinical trials have seen continued growth, with uneven geographical distribution.

In this whitepaper, GlobalData and Novotech analyse key data from 2017-2022, shedding light on the key trends affecting clinical trials. Understand the effects of the COVID-19 pandemic and other macro events, including an impending recession. Discover where the biggest growth opportunities are to be found.

APAC emerges as an outliner when it comes to trial numbers, growth and density. Biotech and pharmaceutical companies should become familiar with the features that could make APAC the primary trial hub of the future.

Novotech - State of the global biotech landscape WP
Enter your details below to receive your free whitepaper


By clicking the “Submit” button above, you accept the Terms & Conditions and acknowledge that your data will be used as described in the Novotech Privacy Policy.

We will also collect and use the information you provide for carefully considered and specific purposes, where we believe we have a legitimate interest in doing so, for example to send you communications about similar products and services we offer. We will always give you an option to opt out of any future communications from us. You can find out more about our legitimate interest activity in our privacy policy here. ‘We’ includes Verdict Media Limited and other GlobalData brands as detailed here.